These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29677352)

  • 21. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding fatigue in adults with visual impairment: A path analysis study of sociodemographic, psychological and health-related factors.
    Schakel W; Bode C; van de Ven PM; van der Aa HPA; Hulshof CTJ; van Rens GHMB; van Nispen RMA
    PLoS One; 2019; 14(10):e0224340. PubMed ID: 31652298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health burden associated with visual impairment in Singapore: the Singapore epidemiology of eye disease study.
    Wang X; Lamoureux E; Zheng Y; Ang M; Wong TY; Luo N
    Ophthalmology; 2014 Sep; 121(9):1837-42. PubMed ID: 24768238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of visual impairment associated with eye diseases: exploratory survey of 298 Chinese patients.
    Guan X; Fu M; Lin F; Zhu D; Vuillermin D; Shi L
    BMJ Open; 2019 Sep; 9(9):e030561. PubMed ID: 31515429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES.
    Brown MM; Brown GC; Lieske HB; Tran I; Turpcu A; Colman S
    Retina; 2016 Feb; 36(2):285-98. PubMed ID: 26428606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the Alexander technique on well-being: a randomised controlled trial involving older adults with visual impairment.
    Gleeson M; Sherrington C; Lo S; Auld R; Keay L
    Clin Exp Optom; 2017 Nov; 100(6):633-641. PubMed ID: 28147451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between visual impairment and fatigue: a systematic review and meta-analysis of observational studies.
    Schakel W; Bode C; Elsman EBM; van der Aa HPA; de Vries R; van Rens GHMB; van Nispen RMA
    Ophthalmic Physiol Opt; 2019 Nov; 39(6):399-413. PubMed ID: 31696537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual Function, Social Position, and Health and Life Chances: The UK Biobank Study.
    Cumberland PM; Rahi JS;
    JAMA Ophthalmol; 2016 Sep; 134(9):959-66. PubMed ID: 27466983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personal costs of visual impairment by different eye diseases and severity of visual loss.
    Wong EY; Chou SL; Lamoureux EL; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(5):339-44. PubMed ID: 18850471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life among people aged ≥65 years with self-reported visual impairment: findings from the 2006-2010 behavioral risk factor surveillance system.
    Crews JE; Chou CF; Zhang X; Zack MM; Saaddine JB
    Ophthalmic Epidemiol; 2014 Oct; 21(5):287-96. PubMed ID: 24955821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health economic burden of patients with restless legs syndrome in a German ambulatory setting.
    Dodel R; Happe S; Peglau I; Mayer G; Wasem J; Reese JP; Giani G; Geraedts M; Trenkwalder C; Oertel WH; Stiasny-Kolster K
    Pharmacoeconomics; 2010; 28(5):381-93. PubMed ID: 20297866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life of the most severely vision-impaired.
    Crewe JM; Morlet N; Morgan WH; Spilsbury K; Mukhtar A; Clark A; Ng JQ; Crowley M; Semmens JB
    Clin Exp Ophthalmol; 2011; 39(4):336-43. PubMed ID: 21070550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Societal costs of fetal alcohol syndrome in Sweden.
    Ericson L; Magnusson L; Hovstadius B
    Eur J Health Econ; 2017 Jun; 18(5):575-585. PubMed ID: 27279344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.